International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1689 - 1689
Published: Jan. 30, 2024
Neurodegenerative
diseases
are
an
increasingly
common
group
of
that
occur
late
in
life
with
a
significant
impact
on
personal,
family,
and
economic
life.
Among
these,
Alzheimer’s
disease
(AD)
Parkinson’s
(PD)
the
major
disorders
lead
to
mild
severe
cognitive
physical
impairment
dementia.
Interestingly,
those
may
show
onset
prodromal
symptoms
early
after
middle
age.
Commonly,
evaluation
these
neurodegenerative
is
based
detection
biomarkers,
where
functional
structural
magnetic
resonance
imaging
(MRI)
have
shown
central
role
revealing
or
phases,
although
it
can
be
expensive,
time-consuming,
not
always
available.
The
aforementioned
visual
system
due
pathophysiological
mechanisms
shared
between
eye
brain.
In
disease,
α-synuclein
deposition
retinal
cells,
as
well
dopaminergic
neurons
substantia
nigra,
alters
cortex
function,
resulting
modifications
field.
Similarly,
modified
by
neurofibrillary
tangles
neuritic
amyloid
β
plaques
typically
seen
brain,
this
reflect
accumulation
biomarkers
retina
during
stages
postmortem
retinas
AD
patients.
light,
ophthalmic
neurodegeneration
could
become
cost-effective
method
for
diagnosis
diseases,
overcoming
limitations
deep
This
analysis
commonly
used
practice,
interest
has
risen
recent
years.
review
will
discuss
relationship
degeneration,
highlighting
how
represent
noninvasive
straightforward
diseases.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(2), P. 736 - 766
Published: Jan. 1, 2023
Cellular
mitophagy
means
that
cells
selectively
wrap
and
degrade
damaged
mitochondria
through
an
autophagy
mechanism,
thus
maintaining
intracellular
homeostasis.In
recent
years,
has
received
increasing
attention
as
a
research
hotspot
related
to
the
pathogenesis
of
clinical
diseases,
such
neurodegenerative
cardiovascular
cancer,
metabolic
so
on.It
been
found
regulation
may
become
new
direction
for
treatment
some
diseases.In
addition,
numerous
small
molecule
modulators
have
also
reported,
which
provides
opportunities
comprehend
procedure
potential
therapeutic
development.Taken
together,
in
this
review,
we
summarize
current
understanding
mechanism
mitophagy,
discuss
roles
its
relationship
with
introduce
existing
small-molecule
pharmacological
further
highlight
significance
their
development.
Annual Review of Pathology Mechanisms of Disease,
Journal Year:
2022,
Volume and Issue:
18(1), P. 95 - 121
Published: Sept. 13, 2022
Parkinson's
disease
(PD)
is
clinically,
pathologically,
and
genetically
heterogeneous,
resisting
distillation
to
a
single,
cohesive
disorder.
Instead,
each
affected
individual
develops
virtually
unique
form
of
syndrome.
Clinical
manifestations
consist
variable
motor
nonmotor
features,
myriad
overlaps
are
recognized
with
other
neurodegenerative
conditions.
Although
most
commonly
characterized
by
alpha-synuclein
protein
pathology
throughout
the
central
peripheral
nervous
systems,
distribution
varies
pathologies
modify
PD
or
trigger
similar
manifestations.
Nearly
all
influenced.
More
than
100
genes
genetic
loci
have
been
identified,
cases
likely
arise
from
interactions
among
many
common
rare
variants.
Despite
its
complex
architecture,
insights
experimental
dissection
coalesce
reveal
unifying
biological
themes,
including
synaptic,
lysosomal,
mitochondrial,
andimmune-mediated
mechanisms
pathogenesis.
This
emerging
understanding
syndrome,
coupled
advances
in
biomarkers
targeted
therapies,
presages
successful
precision
medicine
strategies.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(3)
Published: May 2, 2023
Protein
posttranslational
modifications
(PTMs)
refer
to
the
breaking
or
generation
of
covalent
bonds
on
backbones
amino
acid
side
chains
proteins
and
expand
diversity
proteins,
which
provides
basis
for
emergence
organismal
complexity.
To
date,
more
than
650
types
protein
modifications,
such
as
most
well-known
phosphorylation,
ubiquitination,
glycosylation,
methylation,
SUMOylation,
short-chain
long-chain
acylation
redox
irreversible
have
been
described,
inventory
is
still
increasing.
By
changing
conformation,
localization,
activity,
stability,
charges,
interactions
with
other
biomolecules,
PTMs
ultimately
alter
phenotypes
biological
processes
cells.
The
homeostasis
important
human
health.
Abnormal
may
cause
changes
in
properties
loss
functions,
are
closely
related
occurrence
development
various
diseases.
In
this
review,
we
systematically
introduce
characteristics,
regulatory
mechanisms,
functions
health
addition,
therapeutic
prospects
diseases
by
targeting
associated
enzymes
also
summarized.
This
work
will
deepen
understanding
promote
discovery
diagnostic
prognostic
markers
drug
targets
Clinical Anatomy,
Journal Year:
2021,
Volume and Issue:
35(1), P. 65 - 78
Published: Sept. 24, 2021
Neurodegenerative
disorders
are
characterized
by
progressive
loss
of
particular
populations
neurons.
Apoptosis
has
been
implicated
in
the
pathogenesis
neurodegenerative
diseases,
including
Parkinson
disease,
Alzheimer
Huntington
and
amyotrophic
lateral
sclerosis.
In
this
review,
we
focus
on
existing
notions
relevant
to
comprehending
apoptotic
death
process,
morphological
features,
mediators
regulators
cellular
apoptosis.
We
also
highlight
evidence
neuronal
Additionally,
present
potential
therapeutic
agents
that
could
modify
pathway
aforementioned
diseases
delay
disease
progression.
Finally,
review
clinical
trials
were
conducted
evaluate
use
anti-apoptotic
drugs
treatment
order
essential
need
for
early
detection
intervention
humans.
Translational Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Sept. 18, 2023
A
pathological
feature
of
Parkinson's
disease
(PD)
is
the
progressive
loss
dopaminergic
neurons
and
decreased
dopamine
(DA)
content
in
substantia
nigra
pars
compacta
PD
brains.
DA
neurotransmitter
neurons.
Accumulating
evidence
suggests
that
interacts
with
environmental
genetic
factors
to
contribute
pathophysiology.
Disturbances
synthesis,
storage,
transportation
metabolism
have
been
shown
promote
neurodegeneration
various
models.
unstable
can
undergo
oxidation
produce
multiple
reactive
toxic
by-products,
including
oxygen
species,
quinones,
3,4-dihydroxyphenylacetaldehyde.
Here
we
summarize
highlight
recent
discoveries
on
DA-linked
pathophysiologic
pathways,
discuss
potential
protective
therapeutic
strategies
mitigate
complications
associated
DA.
Neurotherapeutics,
Journal Year:
2023,
Volume and Issue:
21(1), P. e00292 - e00292
Published: Dec. 19, 2023
Recent
advances
in
understanding
the
role
of
mitochondrial
dysfunction
neurodegenerative
diseases
have
expanded
opportunities
for
neurotherapeutics
targeting
mitochondria
to
alleviate
symptoms
and
slow
disease
progression.
In
this
review,
we
offer
a
historical
account
biology
disease.
Additionally,
summarize
current
knowledge
normal
physiology
pathogenesis
dysfunction,
disease,
therapeutics
recent
therapeutic
advances,
as
well
future
directions
function.
A
focus
is
placed
on
reactive
oxygen
species
their
disruption
telomeres
effects
epigenome.
The
etiology
progression
Alzheimer's
amyotrophic
lateral
sclerosis,
Parkinson's
Huntington's
are
discussed
depth.
Current
clinical
trials
mitochondria-targeting
discussed.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: June 20, 2022
Parkinson's
disease
(PD)
is
one
of
the
most
common
neurodegenerative
movement
disorders
worldwide.
There
are
currently
no
cures
or
preventative
treatments
for
PD.
Emerging
evidence
indicates
that
mitochondrial
dysfunction
closely
associated
with
pathogenesis
sporadic
and
familial
Because
dopaminergic
neurons
have
high
energy
demand,
cells
affected
by
PD
exhibit
promotes
disease-defining
loss
in
substantia
nigra
pars
compacta
(SNpc).
The
mitochondrion
has
a
particularly
important
role
as
cellular
"powerhouse"
neurons.
Therefore,
mitochondria
become
promising
therapeutic
target
treatments.
This
review
aims
to
describe
pathology
PD,
outline
genes
factors
related
summarize
current
knowledge
on
quality
control
give
an
overview
strategies
targeting
neuroprotective
interventions
Science Translational Medicine,
Journal Year:
2023,
Volume and Issue:
15(711)
Published: Aug. 30, 2023
Parkinson’s
disease
(PD)
is
the
most
common
neurodegenerative
movement
disorder,
and
neuroprotective
or
disease-modifying
interventions
remain
elusive.
High-throughput
markers
aimed
at
stratifying
patients
on
basis
of
shared
etiology
are
required
to
ensure
success
therapies
in
clinical
trials.
Mitochondrial
dysfunction
plays
a
prominent
role
pathogenesis
PD.
Previously,
we
found
brain
region–specific
accumulation
mitochondrial
DNA
(mtDNA)
damage
PD
neuronal
culture
animal
models,
as
well
human
postmortem
tissue.
To
investigate
mtDNA
potential
blood-based
marker
for
PD,
describe
herein
PCR-based
assay
(Mito
DX
)
that
allows
accurate
real-time
quantification
scalable
platform.
We
was
increased
peripheral
blood
mononuclear
cells
derived
from
with
idiopathic
those
harboring
PD-associated
leucine-rich
repeat
kinase
2
(
LRRK2
G2019S
mutation
comparison
age-matched
controls.
In
addition,
elevated
non–disease-manifesting
carriers,
demonstrating
can
occur
irrespective
diagnosis.
further
established
Lrrk2
knock-in
mice
displayed
damage,
whereas
knockout
showed
fewer
lesions
ventral
midbrain,
compared
wild-type
control
mice.
Furthermore,
small-molecule
inhibitor
mitigated
rotenone
rat
midbrain
neuron
model
patient–derived
lymphoblastoid
cell
lines.
Quantifying
using
Mito
may
have
utility
candidate
measuring
pharmacodynamic
response
inhibitors.
International Journal of Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
53(5)
Published: April 2, 2024
Chronic
neuroinflammation
serves
a
key
role
in
the
onset
and
progression
of
neurodegenerative
disorders.
Mitochondria
serve
as
central
regulators
neuroinflammation.
In
addition
to
providing
energy
cells,
mitochondria
also
participate
immunoinflammatory
response
disorders
including
Alzheimer's
disease,
Parkinson's
multiple
sclerosis
epilepsy,
by
regulating
processes
such
cell
death
inflammasome
activation.
Under
inflammatory
conditions,
mitochondrial
oxidative
stress,
epigenetics,
dynamics
calcium
homeostasis
imbalance
may
underlying
regulatory
mechanisms
for
these
diseases.
Therefore,
investigating
related
dysfunction
result
therapeutic
strategies
against
chronic
neurodegeneration.
The
present
review
summarizes
neuroinflammatory
diseases
current
treatment
approaches
that
target